Intraoperative Neuromonitoring Market Size, Share, and Industry Analysis, By Type (Equipment, and Consumables), By Application (Neurosurgery, ENT Surgery, Orthopedic Surgery, Vascular Surgery, Cardiothoracic Surgery, and Others), By End-user (Hospitals and ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global intraoperative neuromonitoring market size was valued at USD 3.75 billion in 2025. The market is projected to grow from USD 3.98 billion in 2026 to USD 6.34 billion by 2034, exhibiting a CAGR of 6.0% during the forecast period.

The global intraoperative neuromonitoring market is anticipated to expand driven by the high burden of chronic conditions, such as cardiovascular diseases, neurological diseases, and many others across the globe, which increases surgical procedures. Intraoperative neurophysiological monitoring (IONM) consists of continuous monitoring of a patient’s nervous system during complex surgeries. The IONM systems assist surgeons in preventing damage and preserving the functionality of the nervous system. These systems provide early warning to surgeons by providing real-time neurophysiological data during surgical procedures and help to minimize post-operative deficits.

Moreover, the growing initiatives by market players to receive regulatory approvals for the launch of intraoperative neurophysiological monitoring devices is an additional factor driving market growth throughout the forecast period.

• For instance, in July 2024, Soterix Medical Inc., announced that it had received a 510(k) clearance from the U.S. Food & Drug Administration for its intraoperative neurophysiologic monitoring (IOM) system, MEGA-IOM.

Furthermore, the growing geriatric population opting for orthopedic and ENT surgeries is one of the important factors anticipated to drive market growth throughout the forecast period.

Intraoperative Neuromonitoring Market Driver

High Burden of Chronic Disorders to Drive Market Growth

The rising prevalence of chronic illnesses, including cardiovascular diseases, orthopedic diseases, and neurological diseases, among others, has been increasing the demand for surgical procedures, thereby driving market growth.

• For example, as per data provided by the World Health Organization (WHO) in March 2024, over 3 billion people across the world were living with a neurological condition in 2021.
• Additionally, as per data provided by the Mass General Brigham Incorporated in November 2024, more than 900,000 cardiac surgeries, including coronary bypass surgeries, are performed in the U.S. every year, with even more taking place throughout the world.

To know how our report can help streamline your business, Speak to Analyst

As per data provided by Molecular Diversity Preservation International (MDPI) in June 2023, the percentage share of hip replacement surgery in Romania was 23.4% in 2022.

Intraoperative Neuromonitoring Market Restraint

High Cost of Intraoperative Neuromonitoring Devices to Impede Market Growth

Intraoperative neuromonitoring (IONM) devices are widely used during complex surgeries, including cardiovascular, orthopedic, ENT (ear, nose, and throat), and neurological surgeries. The high cost of IONM devices and procedures restricts the market growth significantly, especially for middle-class people and individuals belonging to low-income countries.

• For instance, the retail price for Cascade PRO, an intraoperative neuromonitoring (IONM) system manufactured by Cadwell Industries Inc., is USD 10,495.8 for the base model.
• Similarly, the price of the IONM system, C2 Xplore, developed by inomed Medizintechnik GmbH, is USD 38,754.1.

Moreover, the lack of skilled personnel for managing and maintaining intraoperative neuromonitoring systems is hindering market growth. Furthermore, limited understanding regarding the use of intraoperative neuromonitoring devices, predominantly in emerging countries, is another factor hindering market growth.

Intraoperative Neuromonitoring Market Opportunity

Growing Initiatives by Government Authorities and Other Organizations to Enhance Adoption of IONM Devices

The increasing focus of research organizations on providing funding for research related to neurological disorders and the emphasis of market players on investment in R&D activities to expand their product portfolio is fueling the market growth.

• For instance, as per data provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) in August 2024, the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative awarded approximately 77 new grants between 2021 and 2023, totaling more than USD 91.0 million in research related to NIDCD mission areas.

Moreover, several organizations are actively involved in providing training for healthcare professionals regarding the use of intraoperative neuromonitoring (IONM) devices. Such initiatives increase the adoption of these devices in healthcare settings, thereby fueling market growth.

• For example, in October 2021, the Tata Memorial Centre, located in Mumbai, India, announced a “One Year Certificate Course in IONM.” This training program was mainly focused on the application of intra-operative electrophysiological mapping and monitoring techniques to neuro-oncological and other general oncological surgeries. This course covered theoretical, technical, and practical aspects and included hands-on training on IONM devices.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries, 2023
• Overview: Technological Advancements in Intraoperative Neuromonitoring Devices
• New Product Launches, By Key Players
• Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• Impact of COVID-19 on the Market

Analysis by Type

Based on type, the market is divided into equipment and consumables.

The equipment segment is anticipated to grow significanty over 2024-2032 owing to increasing regulatory approvals and the launch of intraoperative neuromonitoring equipment.

• For instance, in June 2024, Neurosoft announced the launch of Neuro-IOM/Solo, an 8-channel intraoperative neuromonitoring system with a touchscreen designed specifically for use by a surgeon in the European market.

Analysis by Application

On the basis of application, the global intraoperative neuromonitoring market is segmented into neurosurgery, ENT surgery, orthopedic surgery, vascular surgery, cardiothoracic surgery, and others.

The neurosurgery segment held a dominant market share in 2023 and is expected to grow at a significant CAGR during the forecast period. The increasing cases of brain cancer across the globe are generating a huge demand for neurological surgeries, contributing to segmental growth throughout the forecast period.

• For example, as per data provided by the Canadian Cancer Society in May 2024, an estimated 3,200 Canadians were diagnosed with brain and spinal cord cancer in 2023.

Analysis by End-user

Based on end-user, the market is divided into hospitals and ASCs, specialty clinics, and others.

The hospitals and ASCs segment is projected to grow at a significant CAGR over 2024 to 2032. The high growth rate of the segment is majorly due to the increasing hospitalizations for several types of complex surgeries across the globe.

• For instance, as per data provided by the National Adult Cardiac Surgery Audit (NACSA) 2024, each cardiac surgical center with National Health Service (NHS) hospitals performed 757 adult cardiac operations in 2023.

Therefore, increasing hospitalizations for complicated surgeries, including cardiovascular surgeries, ultimately increases the adoption of intraoperative neuromonitoring systems and related accessories, boosting segmental growth throughout the forecast period.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a major share of the global intraoperative neuromonitoring market in 2023 and is expected to grow at the highest CAGR from 2024-2032. The rising focus of market players on receiving regulatory approvals for the launch of intraoperative neuromonitoring devices is one of the main factors driving regional market growth.

• For example, in October 2020, Medtronic announced that the U.S. Food and Drug Administration (FDA) approved the NIM Vital nerve monitoring system, which enables physicians to identify, confirm, and monitor nerve function to help reduce the risk of nerve damage during head and neck surgery.

Furthermore, the presence of key companies providing intraoperative neuromonitoring devices in North America, such as Cadwell Industries Inc., Natus Medical Incorporated, and NuVasive, Inc., is an additional factor fueling the market growth.

Europe accounted for a moderate market share in 2023 and is expected to grow at a considerable CAGR during the forecast period. The increasing number of complex surgeries, including neurological surgeries, cardiothoracic surgeries, and orthopedic surgeries, is one of the major factors boosting the regional market growth.

Key Players Covered

The global intraoperative neuromonitoring market consists of companies such as Medtronic, inomed Medizintechnik GmbH, Nihon Kohden Corporation, and Neurosoft, among other players.

The report includes the profiles of the following key players:

• Medtronic (Ireland)
• inomed Medizintechnik GmbH (Germany)
• Nihon Kohden Corporation (Japan)
• Cadwell Industries Inc. (U.S.)
• Neurovision Medical Products (U.S.)
• Neurosoft (Greece)
• Johnson & Johnson Services, Inc. (U.S.)
• NuVasive, Inc. (U.S.)
• Natus Medical Incorporated (U.S.)

Key Industry Developments

• In September 2022, Brainlab AG announced the acquisition of Dr. Langer Medical GmbH, a German firm that specializes in the development of intraoperative neuromonitoring solutions and related equipment for surgical interventions.
• In April 2021, Assure Neuromonitoring, LLC., a provider of intraoperative neuromonitoring services (“IONM”), acquired the assets of Elevation EP, LLC, a Texas-based IONM service provider. The company acquired Elevation’s contracts, employees, business relationships, and assets.
• In February 2021, Assure Neuromonitoring, LLC., a provider of intraoperative neuromonitoring services (“IONM”), acquired Sentry Neuromonitoring, LLC, one of the largest IONM service providers in Texas, for a purchase price of USD 3,500,000.